Related Articles
Clinical effect of ticagrelor administered in acute coronary syndrome patients following percutaneous coronary intervention
Influence of CYP2C19 genotype on antiplatelet treatment outcomes after percutaneous coronary intervention in patients with coronary heart disease
Clinical characteristics of patients with premature acute coronary syndrome and adverse cardiovascular events after PCI
Thromboembolic events secondary to tirofiban-induced thrombocytopenia being treated with thrombopoietin: A case report
Spontaneous hematoma in the setting of dual anti-platelet therapy with ticagrelor: A case report